Live Breaking News & Updates on Alla Patlis

Stay updated with breaking news from Alla patlis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded. ....

Michael Wood , David Bautz , Stacy Lindborg , William Barr , Juno Pharma , Chaim Lebovits , Advisory Committee , Brainstorm Cell Therapeutics Inc , Cap Research , Brainstorm Cell Therapeutics , Call Transcript November , Brainstorm Cell Therapeutics Third Quarter , Co Chief Executive Officer , Alla Patlis , Interim Chief Financial , Special Protocol Assessment , With The Lowest Female Employment , Producing Countries , Zacks Small Cap , Tedium Adventures ,

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder this call is being recorded. ....

United States , Antonio Trejo , Chaim Lebovits , Kirk Taylor , Stacy Lindborg , David Bautz , Michael Wood , Richard Robbins , Dan Michael , Vp Regulatory Affairs , Research Summit , Brainstorm Cell Therapeutics Inc , Advisory Committee Meeting , Vp North American Medical Affairs , Company Executive , Association Clinical , Brainstorm Cell Therapeutics , Call Transcript May , Cell Therapeutics , Brainstorm Cell Therapeutics First Quarter , Co Chief Executive Officer , Alla Patlis , Interim Chief Financial , Chief Medical Officer , Nurown Phase , Muscular Dystrophy ,

BrainStorm to Announce First Quarter 2023 Financial Results and Provide a Corporate Update

NEW YORK, May 9, 2023 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference. | May 9, 2023 ....

United States , John Mullaly , Stacy Lindborg , Kirk Taylor , Lisa Guiterman , Chaim Lebovits , Brainstorm Cell Therapeutics Inc , Lifesci Advisors , California Institute For Regenerative Medicine , Prnewswire Brainstorm Cell Therapeutics Inc , Drug Administration , National Ms Society , European Medicines Agency , Storm Cell Therapeutics , First Quarter , Chief Executive Officer , Co Chief Executive Officer , Executive Vice President , Chief Medical Officer , Alla Patlis , Interim Chief Financial , Orphan Drug , California Institute , Regenerative Medicine , Harbor Statement , Brainstorm Cell Therapeutics ,

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. ....

United States , Michael Wood , Chaim Lebovits , Jason Mccarthy , Stacy Lindborg , Raymond James , David Setboun , Health Photo , Association Clinical , Jason Mccarthy At Maxim Group , Access Program , Brainstorm Cell Therapeutics Inc , Brainstorm Cell Therapeutics , Call Transcript March , Brainstorm Cell Therapeutics Fourth Quarter , Chaim Lebovits President , Co Chief Executive Officer , Alla Patlis , Interim Chief Financial , Chief Operating Officer , File Over Protest , Annual Muscular Dystrophy , Info Mycellhub , Expanded Access , Expanded Access Program , Paying Jobs ,

BrainStorm to Announce Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today. ....

United States , John Mullaly , David Setboun , Chaim Lebovits , Lisa Guiterman , Stacy Lindborg , California Institute For Regenerative Medicine , Brainstorm Cell Therapeutics Inc , Lifesci Advisors , Drug Administration , Prnewswire Brainstorm Cell Therapeutics Inc , National Ms Society , European Medicines Agency , Storm Cell Therapeutics , Chief Executive Officer , Co Chief Executive Officer , Executive Vice President , Chief Operating Officer , Alla Patlis , Interim Chief Financial , Replay Number , Replay Expiration , Orphan Drug , California Institute , Regenerative Medicine , Harbor Statement ,